v ::INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES::
ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

EFFECTIVENESS OF COGNITIVE BEHAVIOURAL THERAPY IN PATIENTS SUFFERING FROM INSOMNIA

AUTHORS:

Dr. Syed Jaffer*, Safa Amreen Salim Awad, Mohammed Owais Aslam, Dr. Ahmed Minhajuddin

ABSTRACT:

Background: Insomnia is common in primary care and can persist after co-morbid conditions are treated and may require long-term medication treatment. There is now evidence to suggest that insomnia often persists following resolution of co-morbid conditions, and that it generally does not spontaneously resolve over time if left untreated A potential alternative to medications is cognitive behavioural therapy for insomnia (CBT-I). Objective: To study the effectiveness of CBT in patients suffering from insomnia. Method: A prospective and observational study was carried out for 6 months. The information was obtained from patient data sheets patient interview. It was recorded in data collection forms. The influence of CBT was observed in the patients. Result: Out of 127 patients, 39% patients were male and 61% were females. The most effected age group was found to be 18-30 years. Out of the 127 patients counselled, 49 patients were followed up in the 4th months, 31 patients were followed up in the 5th month and 27 patients were followed up till the 6th month. Maximum patients were in the ISI category of 8-14 (sub threshold insomnia). Comparison of the ISI score after cognitive behavioural therapy showed that there was an overall improvement in their sleep pattern and decreased sleep onset latency was seen. Conclusion: Upon following the right measures of patient counselling, stimulus control therapy, sleep hygiene, a favourable outcome was seen in patients suffering with sub threshold insomnia and moderately severe insomnia with their sleep pattern showing a substantial improvement. Keywords: Insomnia, Sleep, Cognitive therapy, Behavioural therapy, insomnia severity index.

FULL TEXT

Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.